{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2", "Traditional Chinese medicine", "machine learning"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36615401", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "26"}], "Language": ["eng"], "ELocationID": ["208", "10.3390/molecules28010208"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "26"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning.", "Abstract": {"AbstractText": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, is spreading rapidly and has caused hundreds of millions of infections and millions of deaths worldwide. Due to the lack of specific vaccines and effective treatments for COVID-19, there is an urgent need to identify effective drugs. Traditional Chinese medicine (TCM) is a valuable resource for identifying novel anti-SARS-CoV-2 drugs based on the important contribution of TCM and its potential benefits in COVID-19 treatment. Herein, we aimed to discover novel anti-SARS-CoV-2 compounds and medicinal plants from TCM by establishing a prediction method of anti-SARS-CoV-2 activity using machine learning methods. We first constructed a benchmark dataset from anti-SARS-CoV-2 bioactivity data collected from the ChEMBL database. Then, we established random forest (RF) and support vector machine (SVM) models that both achieved satisfactory predictive performance with AUC values of 0.90. By using this method, a total of 1011 active anti-SARS-CoV-2 compounds were predicted from the TCMSP database. Among these compounds, six compounds with highly potent activity were confirmed in the anti-SARS-CoV-2 experiments. The molecular fingerprint similarity analysis revealed that only 24 of the 1011 compounds have high similarity to the FDA-approved antiviral drugs, indicating that most of the compounds were structurally novel. Based on the predicted anti-SARS-CoV-2 compounds, we identified 74 anti-SARS-CoV-2 medicinal plants through enrichment analysis. The 74 plants are widely distributed in 68 genera and 43 families, 14 of which belong to antipyretic detoxicate plants. In summary, this study provided several medicinal plants with potential anti-SARS-CoV-2 activity, which offer an attractive starting point and a broader scope to mine for potentially novel anti-SARS-CoV-2 drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, China."}, {"Identifier": [], "Affiliation": "Yunnan Key Laboratory of Primate Biomedical Research, Kunming 650500, China."}], "LastName": "Liang", "ForeName": "Jihao", "Initials": "J"}, {"Identifier": ["0000-0002-3236-6598"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, China."}, {"Identifier": [], "Affiliation": "Yunnan Key Laboratory of Primate Biomedical Research, Kunming 650500, China."}], "LastName": "Zheng", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, China."}, {"Identifier": [], "Affiliation": "Yunnan Key Laboratory of Primate Biomedical Research, Kunming 650500, China."}], "LastName": "Tong", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, China."}, {"Identifier": [], "Affiliation": "Yunnan Key Laboratory of Primate Biomedical Research, Kunming 650500, China."}], "LastName": "Yang", "ForeName": "Naixue", "Initials": "N"}, {"Identifier": ["0000-0002-6919-2034"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, China."}, {"Identifier": [], "Affiliation": "Yunnan Key Laboratory of Primate Biomedical Research, Kunming 650500, China."}], "LastName": "Dai", "ForeName": "Shaoxing", "Initials": "S"}], "GrantList": [{"GrantID": "No. 32160153", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "No. 202001BC070001 and 202102AA100053", "Agency": "Natural Science Foundation of Yunnan Province", "Country": ""}, {"GrantID": "No. 2019FB050 and 202105AD160008", "Agency": "the Yunnan Fundamental Research Projects", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Cheminformatics"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Machine Learning"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ortiz-Prado E., Simbana-Rivera K., Gomez-Barreno L., Rubio-Neira M., Guaman L.P., Kyriakidis N.C., Muslin C., Jaramillo A.M.G., Barba-Ostria C., Cevallos-Robalino D., et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn. Microbiol. Infect. Dis. 2020;98:115094. doi: 10.1016/j.diagmicrobio.2020.115094.", "ArticleIdList": ["10.1016/j.diagmicrobio.2020.115094", "PMC7260568", "32623267"]}, {"Citation": "Huang C.L., Wang Y.M., Li X.W., Ren L.L., Zhao J.P., Hu Y., Zhang L., Fan G.H., Xu J.Y., Gu X.Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "WHO  Coronavirus Disease (COVID-19) Dashboard.  [(accessed on 5 October 2022)].  Available online:  https://covid19.who.int/"}, {"Citation": "Zhang L., Zhou R. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase. J. Phys. Chem. B. 2020;124:6955\u20136962. doi: 10.1021/acs.jpcb.0c04198.", "ArticleIdList": ["10.1021/acs.jpcb.0c04198", "32521159"]}, {"Citation": "Yip A.J.W., Low Z.Y., Chow V.T.K., Lal S.K. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity. Viruses. 2022;14:1345. doi: 10.3390/v14061345.", "ArticleIdList": ["10.3390/v14061345", "PMC9228778", "35746815"]}, {"Citation": "Extance A. COVID-19: What is the evidence for the antiviral Paxlovid? BMJ Br. Med. J. 2022;377:o1037. doi: 10.1136/bmj.o1037.", "ArticleIdList": ["10.1136/bmj.o1037", "35477536"]}, {"Citation": "Tao K.M., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Pond S.L.K., Fera D., Shafer R.W. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 2021;22:757\u2013773. doi: 10.1038/s41576-021-00408-x.", "ArticleIdList": ["10.1038/s41576-021-00408-x", "PMC8447121", "34535792"]}, {"Citation": "Thomson E.C., Willett B.J. Omicron: A shift in the biology of SARS-CoV-2. Nat. Microbiol. 2022;7:1114\u20131115.", "ArticleIdList": ["35821416"]}, {"Citation": "Gandhi S., Klein J., Robertson A., Pena-Hernandez M.A., Lin M.J., Roychoudhury P., Lu P.W., Fournier J., Ferguson D., Bakhash S.A.M., et al. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report. Nat. Commun. 2022;13:1547. doi: 10.1038/s41467-022-29104-y.", "ArticleIdList": ["10.1038/s41467-022-29104-y", "PMC8930970", "35301314"]}, {"Citation": "Chaudhuri S., Symons J.A., Deval J. Innovation and trends in the development and approval of antiviral medicines: 1987\u20132017 and beyond. Antivir. Res. 2018;155:76\u201388. doi: 10.1016/j.antiviral.2018.05.005.", "ArticleIdList": ["10.1016/j.antiviral.2018.05.005", "PMC7126013", "29758235"]}, {"Citation": "Vitiello A. SARS-CoV-2 and risk of antiviral drug resistance. Ir. J. Med. Sci. 2022;191:2367\u20132368. doi: 10.1007/s11845-021-02820-y.", "ArticleIdList": ["10.1007/s11845-021-02820-y", "PMC8554178", "34714491"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV) Biosci. Trends. 2020;14:69\u201371. doi: 10.5582/bst.2020.01020.", "ArticleIdList": ["10.5582/bst.2020.01020", "31996494"]}, {"Citation": "Xu J., Zhang Y. Traditional Chinese medicine treatment of COVID-19. Complement. Ther. Clin. Pract. 2020;39:101165. doi: 10.1016/j.ctcp.2020.101165.", "ArticleIdList": ["10.1016/j.ctcp.2020.101165", "PMC7118627", "32379692"]}, {"Citation": "Du H.Z., Hou X.Y., Miao Y.H., Huang B.S., Liu D.H. Traditional Chinese Medicine: An effective treatment for 2019 novel coronavirus pneumonia (NCP) Chin. J. Nat. Med. 2020;18:206\u2013210. doi: 10.1016/S1875-5364(20)30022-4.", "ArticleIdList": ["10.1016/S1875-5364(20)30022-4", "PMC7270732", "32245590"]}, {"Citation": "Huang Y.F., Bai C., He F., Xie Y., Zhou H. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19) Pharmacol. Res. 2020;158:104939. doi: 10.1016/j.phrs.2020.104939.", "ArticleIdList": ["10.1016/j.phrs.2020.104939", "PMC7239792", "32445956"]}, {"Citation": "Wei P.F. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) Chin. Med. J. Peking. 2020;133:1087\u20131095.", "ArticleIdList": ["PMC7213636", "32358325"]}, {"Citation": "Guo Y.J., Ma A.N., Wang X.Y., Yang C., Chen X., Li G., Qiu F. Research progress on the antiviral activities of natural products and their derivatives: Structure-activity relationships. Front. Chem. 2022;10:1005360. doi: 10.3389/fchem.2022.1005360.", "ArticleIdList": ["10.3389/fchem.2022.1005360", "PMC9596788", "36311429"]}, {"Citation": "Mukhtar M., Arshad M., Ahmad M., Pomerantz R.J., Wigdahl B., Parveen Z. Antiviral potentials of medicinal plants. Virus Res. 2008;131:111\u2013120. doi: 10.1016/j.virusres.2007.09.008.", "ArticleIdList": ["10.1016/j.virusres.2007.09.008", "PMC7114233", "17981353"]}, {"Citation": "Ali S.I., Sheikh W.M., Rather M.A., Venkatesalu V., Bashir S.M., Nabi S.U. Medicinal plants: Treasure for antiviral drug discovery. Phytother. Res. 2021;35:3447\u20133483. doi: 10.1002/ptr.7039.", "ArticleIdList": ["10.1002/ptr.7039", "PMC8013762", "33590931"]}, {"Citation": "Akram M., Tahir I.M., Shah S.M.A., Mahmood Z., Altaf A., Ahmad K., Munir N., Daniyal M., Nasir S., Mehboob H. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review. Phytother. Res. 2018;32:811\u2013822. doi: 10.1002/ptr.6024.", "ArticleIdList": ["10.1002/ptr.6024", "29356205"]}, {"Citation": "Zandi K., Musall K., Oo A., Cao D., Liang B., Hassandarvish P., Lan S., Slack R.L., Kirby K.A., Bassit L., et al. Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase. Microorganisms. 2021;9:893. doi: 10.3390/microorganisms9050893.", "ArticleIdList": ["10.3390/microorganisms9050893", "PMC8143456", "33921971"]}, {"Citation": "Chen F., Chan K.H., Jiang Y., Kao R.Y., Lu H.T., Fan K.W., Cheng V.C., Tsui W.H., Hung I.F., Lee T.S., et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 2004;31:69\u201375. doi: 10.1016/j.jcv.2004.03.003.", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "PMC7128415", "15288617"]}, {"Citation": "Van de Sand L., Bormann M., Alt M., Schipper L., Heilingloh C.S., Steinmann E., Todt D., Dittmer U., Elsner C., Witzke O., et al. Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease. Viruses. 2021;13:609. doi: 10.3390/v13040609.", "ArticleIdList": ["10.3390/v13040609", "PMC8066091", "33918301"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046. doi: 10.1016/S0140-6736(03)13615-X.", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Fan H., He S.T., Han P., Hong B., Liu K., Li M., Wang S., Tong Y. Cepharanthine: A Promising Old Drug against SARS-CoV-2. Adv. Biol. 2022;6:e2200148. doi: 10.1002/adbi.202200148.", "ArticleIdList": ["10.1002/adbi.202200148", "PMC9350037", "35775953"]}, {"Citation": "Chen Y., de Lomana M.G., Friedrich N.O., Kirchmair J. Characterization of the Chemical Space of Known and Readily Obtainable Natural Products. J. Chem. Inf. Model. 2018;58:1518\u20131532. doi: 10.1021/acs.jcim.8b00302.", "ArticleIdList": ["10.1021/acs.jcim.8b00302", "30010333"]}, {"Citation": "Sucher N.J. The application of Chinese medicine to novel drug discovery. Expert Opin. Drug Discov. 2013;8:21\u201334. doi: 10.1517/17460441.2013.739602.", "ArticleIdList": ["10.1517/17460441.2013.739602", "23170842"]}, {"Citation": "Ma N., Zhang Z., Liao F., Jiang T., Tu Y. The birth of artemisinin. Pharmacol. Ther. 2020;216:107658. doi: 10.1016/j.pharmthera.2020.107658.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107658", "32777330"]}, {"Citation": "Torjesen I. Drug development: The journey of a medicine from lab to shel. Pharm. J. 2015 doi: 10.1211/PJ.2015.20068196.", "ArticleIdList": ["10.1211/PJ.2015.20068196"]}, {"Citation": "Zhao Y., Tian Y., Pan C., Liang A., Zhang W., Sheng Y. Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2. Interdiscip. Sci. 2022;14:64\u201379.", "ArticleIdList": ["PMC8310681", "34308530"]}, {"Citation": "Qi X., Li B., Omarini A.B., Gand M., Zhang X., Wang J. Discovery of TCMs and derivatives against the main protease of SARS-CoV-2 via high throughput screening, ADMET analysis, and inhibition assay in vitro. J. Mol. Struct. 2022;1268:133709. doi: 10.1016/j.molstruc.2022.133709.", "ArticleIdList": ["10.1016/j.molstruc.2022.133709", "PMC9273959", "35846732"]}, {"Citation": "De Oliveira O.V., Costa M.C.A., da Costa R.M., Viegas R.G., Paluch A.S., Ferreira M.M.C. Traditional herbal compounds as candidates to inhibit the SARS-CoV-2 main protease: An in silico study. J. Biomol. Struct. Dyn. 2021:1\u201314. doi: 10.1080/07391102.2021.2023646.", "ArticleIdList": ["10.1080/07391102.2021.2023646"]}, {"Citation": "Kadioglu O., Saeed M., Greten H.J., Efferth T. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Comput. Biol. Med. 2021;133:104359. doi: 10.1016/j.compbiomed.2021.104359.", "ArticleIdList": ["10.1016/j.compbiomed.2021.104359", "PMC8008812", "33845270"]}, {"Citation": "Patel C.N., Goswami D., Jaiswal D.G., Jani S.P., Parmar R.M., Rawal R.M., Pandya H.A. Excavating phytochemicals from plants possessing antiviral activities for identifying SARS-CoV hemagglutinin-esterase inhibitors by diligent computational workflow. J. Biomol. Struct. Dyn. 2022:1\u201316. doi: 10.1080/07391102.2022.2033642.", "ArticleIdList": ["10.1080/07391102.2022.2033642", "35098887"]}, {"Citation": "Yi Y., Li J.H., Lai X.Y., Zhang M., Kuang Y., Bao Y.O., Yu R., Hong W., Muturi E., Xue H., et al. Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection. J. Adv. Res. 2022;36:201\u2013210. doi: 10.1016/j.jare.2021.11.012.", "ArticleIdList": ["10.1016/j.jare.2021.11.012", "PMC8620242", "35116174"]}, {"Citation": "Jan J.-T., Cheng T.-J.R., Juang Y.-P., Ma H.-H., Wu Y.-T., Yang W.-B., Cheng C.-W., Chen X., Chou T.-H., Shie J.-J. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proc. Natl. Acad. Sci. USA. 2021;118:e2021579118. doi: 10.1073/pnas.2021579118.", "ArticleIdList": ["10.1073/pnas.2021579118", "PMC7865145", "33452205"]}, {"Citation": "Gonzalez-Maldonado P., Alvarenga N., Burgos-Edwards A., Flores-Giubi M.E., Barua J.E., Romero-Rodriguez M.C., Soto-Rifo R., Valiente-Echeverria F., Langjahr P., Cantero-Gonzalez G., et al. Screening of Natural Products Inhibitors of SARS-CoV-2 Entry. Molecules. 2022;27:1743. doi: 10.3390/molecules27051743.", "ArticleIdList": ["10.3390/molecules27051743", "PMC8911944", "35268843"]}, {"Citation": "Paul D., Sanap G., Shenoy S., Kalyane D., Kalia K., Tekade R.K. Artificial intelligence in drug discovery and development. Drug Discov. Today. 2021;26:80\u201393. doi: 10.1016/j.drudis.2020.10.010.", "ArticleIdList": ["10.1016/j.drudis.2020.10.010", "PMC7577280", "33099022"]}, {"Citation": "Rosado J., Pelleau S., Cockram C., Merkling S.H., Nekkab N., Demeret C., Meola A., Kerneis S., Terrier B., Fafi-Kremer S., et al. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: An antibody-based diagnostic and machine learning study. Lancet Microbe. 2021;2:e60\u2013e69. doi: 10.1016/S2666-5247(20)30197-X.", "ArticleIdList": ["10.1016/S2666-5247(20)30197-X", "PMC7837364", "33521709"]}, {"Citation": "Zoabi Y., Deri-Rozov S., Shomron N. Machine learning-based prediction of COVID-19 diagnosis based on symptoms. NPJ Digit. Med. 2021;4:3. doi: 10.1038/s41746-020-00372-6.", "ArticleIdList": ["10.1038/s41746-020-00372-6", "PMC7782717", "33398013"]}, {"Citation": "Jin W., Stokes J.M., Eastman R.T., Itkin Z., Zakharov A.V., Collins J.J., Jaakkola T.S., Barzilay R. Deep learning identifies synergistic drug combinations for treating COVID-19. Proc. Natl. Acad. Sci. USA. 2021;118:e2105070118. doi: 10.1073/pnas.2105070118.", "ArticleIdList": ["10.1073/pnas.2105070118", "PMC8488647", "34526388"]}, {"Citation": "Lalmuanawma S., Hussain J., Chhakchhuak L. Applications of machine learning and artificial intelligence for COVID-19 (SARS-CoV-2) pandemic: A review. Chaos Solitons Fractals. 2020;139:110059. doi: 10.1016/j.chaos.2020.110059.", "ArticleIdList": ["10.1016/j.chaos.2020.110059", "PMC7315944", "32834612"]}, {"Citation": "D\u2019Souza S., Prema K.V., Balaji S. Machine learning models for drug-target interactions: Current knowledge and future directions. Drug Discov. Today. 2020;25:748\u2013756. doi: 10.1016/j.drudis.2020.03.003.", "ArticleIdList": ["10.1016/j.drudis.2020.03.003", "32171918"]}, {"Citation": "Nand M., Maiti P., Joshi T., Chandra S., Pande V., Kuniyal J.C., Ramakrishnan M.A. Virtual screening of anti-HIV1 compounds against SARS-CoV-2: Machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis. Sci. Rep. 2020;10:20397. doi: 10.1038/s41598-020-77524-x.", "ArticleIdList": ["10.1038/s41598-020-77524-x", "PMC7683650", "33230180"]}, {"Citation": "Ivanov J., Polshakov D., Kato-Weinstein J., Zhou Q.Q., Li Y.Z., Granet R., Garner L., Deng Y., Liu C., Albaiu D., et al. Quantitative Structure-Activity Relationship Machine Learning Models and their Applications for Identifying Viral 3CLpro-and RdRp-Targeting Compounds as Potential Therapeutics for COVID-19 and Related Viral Infections. ACS Omega. 2020;5:27344\u201327358. doi: 10.1021/acsomega.0c03682.", "ArticleIdList": ["10.1021/acsomega.0c03682", "PMC7571315", "33134697"]}, {"Citation": "Qamar M.T.U., Zhu X.T., Chen L.L., Alhussain L., Alshiekheid M.A., Theyab A., Algahtani M. Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development. Int. J. Mol. Sci. 2022;23:11003. doi: 10.3390/ijms231911003.", "ArticleIdList": ["10.3390/ijms231911003", "PMC9570399", "36232307"]}, {"Citation": "Xu T., Xu M., Zhu W., Chen C.Z., Zhang Q., Zheng W., Huang R. Efficient Identification of Anti-SARS-CoV-2 Compounds Using Chemical Structure- and Biological Activity-Based Modeling. J. Med. Chem. 2022;65:4590\u20134599. doi: 10.1021/acs.jmedchem.1c01372.", "ArticleIdList": ["10.1021/acs.jmedchem.1c01372", "PMC8936051", "35275639"]}, {"Citation": "Gawriljuk V.O., Zin P.P.K., Puhl A.C., Zorn K.M., Foil D.H., Lane T.R., Hurst B., Tavella T.A., Costa F.T.M., Lakshmanane P., et al. Machine Learning Models Identify Inhibitors of SARS-CoV-2. J. Chem. Inf. Model. 2021;61:4224\u20134235. doi: 10.1021/acs.jcim.1c00683.", "ArticleIdList": ["10.1021/acs.jcim.1c00683", "PMC8574161", "34387990"]}, {"Citation": "Rajput A., Kumar A., Megha K., Thakur A., Kumar M. DrugRepV: A compendium of repurposed drugs and chemicals targeting epidemic and pandemic viruses. Brief Bioinform. 2021;22:1076\u20131084. doi: 10.1093/bib/bbaa421.", "ArticleIdList": ["10.1093/bib/bbaa421", "PMC7929368", "33480398"]}, {"Citation": "Li Y., Tian Y., Qin Z., Yan A. Classification of HIV-1 Protease Inhibitors by Machine Learning Methods. ACS Omega. 2018;3:15837\u201315849. doi: 10.1021/acsomega.8b01843.", "ArticleIdList": ["10.1021/acsomega.8b01843", "PMC6288788", "30556015"]}, {"Citation": "Feunang Y.D., Eisner R., Knox C., Chepelev L., Hastings J., Owen G., Fahy E., Steinbeck C., Subramanian S., Bolton E., et al. ClassyFire: Automated chemical classification with a comprehensive, computable taxonomy. J. Cheminform. 2016;8:61. doi: 10.1186/s13321-016-0174-y.", "ArticleIdList": ["10.1186/s13321-016-0174-y", "PMC5096306", "27867422"]}, {"Citation": "Molavi Z., Razi S., Mirmotalebisohi S.A., Adibi A., Sameni M., Karami F., Niazi V., Niknam Z., Aliashrafi M., Taheri M., et al. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Biomed. Pharmacother. 2021;138:111544. doi: 10.1016/j.biopha.2021.111544.", "ArticleIdList": ["10.1016/j.biopha.2021.111544", "PMC8011644", "34311539"]}, {"Citation": "Patel C.N., Jani S.P., Sivakumar P.K., Modi K.M., Kumar Y. Medicine, Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus. Comput. Biol. Med. 2022;151:106318. doi: 10.1016/j.compbiomed.2022.106318.", "ArticleIdList": ["10.1016/j.compbiomed.2022.106318", "PMC9673090", "36423529"]}, {"Citation": "Mosquera-Yuqui F., Lopez-Guerra N., Moncayo-Palacio E.A. Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: Molecular docking and molecular dynamics simulations. J. Biomol. Struct. Dyn. 2022;40:2010\u20132023. doi: 10.1080/07391102.2020.1835716.", "ArticleIdList": ["10.1080/07391102.2020.1835716", "PMC7657401", "33084512"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2012;64:4\u201317. doi: 10.1016/j.addr.2012.09.019.", "ArticleIdList": ["10.1016/j.addr.2012.09.019", "11259830"]}, {"Citation": "Huang B., Zhang Y. Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives. Drug Discov. Today. 2022;27:1936\u20131944. doi: 10.1016/j.drudis.2022.02.007.", "ArticleIdList": ["10.1016/j.drudis.2022.02.007", "PMC9232944", "35182736"]}, {"Citation": "Song M.R., Liu Y., Li T.T., Liu X.J., Hao Z.H., Ding S.Y., Panichayupakaranant P., Zhu K., Shen J.Z. Plant Natural Flavonoids Against Multidrug Resistant Pathogens. Adv. Sci. 2021;8:e2100749. doi: 10.1002/advs.202100749.", "ArticleIdList": ["10.1002/advs.202100749", "PMC8336499", "34041861"]}, {"Citation": "Liskova A., Koklesova L., Samec M., Smejkal K., Samuel S.M., Varghese E., Abotaleb M., Biringer K., Kudela E., Danko J., et al. Flavonoids in Cancer Metastasis. Cancers. 2020;12:1498. doi: 10.3390/cancers12061498.", "ArticleIdList": ["10.3390/cancers12061498", "PMC7352928", "32521759"]}, {"Citation": "Al-Khayri J.M., Sahana G.R., Nagella P., Joseph B.V., Alessa F.M., Al-Mssallem M.Q. Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules. 2022;27:2901. doi: 10.3390/molecules27092901.", "ArticleIdList": ["10.3390/molecules27092901", "PMC9100260", "35566252"]}, {"Citation": "Liskova A., Samec M., Koklesova L., Samuel S.M., Zhai K., Al-Ishaq R.K., Abotaleb M., Nosal V., Kajo K., Ashrafizadeh M., et al. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed. Pharmacother. 2021;138:111430. doi: 10.1016/j.biopha.2021.111430.", "ArticleIdList": ["10.1016/j.biopha.2021.111430", "PMC7906511", "33662680"]}, {"Citation": "Kaul T.N., Middleton E., Jr., Ogra P.L. Antiviral effect of flavonoids on human viruses. J. Med. Virol. 1985;15:71\u201379. doi: 10.1002/jmv.1890150110.", "ArticleIdList": ["10.1002/jmv.1890150110", "2981979"]}, {"Citation": "Lani R., Hassandarvish P., Shu M.H., Phoon W.H., Chu J.J.H., Higgs S., Vanlandingham D., Abu Bakar S., Zandi K. Antiviral activity of selected flavonoids against Chikungunya virus. Antivir. Res. 2016;133:50\u201361. doi: 10.1016/j.antiviral.2016.07.009.", "ArticleIdList": ["10.1016/j.antiviral.2016.07.009", "27460167"]}, {"Citation": "Cataneo A.H.D., Avila E.P., Mendes L.A.D., de Oliveira V.G., Ferraz C.R., de Almeida M.V., Frabasile S., dos Santos C.N.D., Verri W.A., Bordignon J., et al. Flavonoids as Molecules with Anti-Zika virus Activity. Front. Microbiol. 2021;12:710359. doi: 10.3389/fmicb.2021.710359.", "ArticleIdList": ["10.3389/fmicb.2021.710359", "PMC8462986", "34566915"]}, {"Citation": "Abian O., Ortega-Alarcon D., Jimenez-Alesanco A., Ceballos-Laita L., Vega S., Reyburn H.T., Rizzuti B., Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int. J. Biol. Macromol. 2020;164:1693\u20131703. doi: 10.1016/j.ijbiomac.2020.07.235.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.07.235", "PMC7395220", "32745548"]}, {"Citation": "Xiao T., Cui M., Zheng C., Wang M., Sun R., Gao D., Bao J., Ren S., Yang B., Lin J., et al. Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation. Front. Pharmacol. 2021;12:669642. doi: 10.3389/fphar.2021.669642.", "ArticleIdList": ["10.3389/fphar.2021.669642", "PMC8248548", "34220507"]}, {"Citation": "Al-Maharik N. Isolation of naturally occurring novel isoflavonoids: An update. Nat. Prod. Rep. 2019;36:1156\u20131195. doi: 10.1039/C8NP00069G.", "ArticleIdList": ["10.1039/C8NP00069G", "30632588"]}, {"Citation": "Matos M.J. Coumarin and Its Derivatives-Editorial. Molecules. 2021;26:6320. doi: 10.3390/molecules26206320.", "ArticleIdList": ["10.3390/molecules26206320", "PMC8538651", "34684900"]}, {"Citation": "Xu W., Zhang M., Liu H., Wei K., He M., Li X., Hu D., Yang S., Zheng Y. Antiviral activity of aconite alkaloids from Aconitum carmichaelii Debx. Nat. Prod. Res. 2019;33:1486\u20131490. doi: 10.1080/14786419.2017.1416385.", "ArticleIdList": ["10.1080/14786419.2017.1416385", "29271255"]}, {"Citation": "Xu X., Han M., Li T., Sun W., Wang D., Fu B., Zhou Y., Zheng X., Yang Y., Li X., et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl. Acad. Sci. USA. 2020;117:10970\u201310975. doi: 10.1073/pnas.2005615117.", "ArticleIdList": ["10.1073/pnas.2005615117", "PMC7245089", "32350134"]}, {"Citation": "Liuzzo G., Patrono C. COVID 19: In the eye of the cytokine storm. Eur. Heart J. 2021;42:150\u2013151.", "ArticleIdList": ["PMC7799110", "33462598"]}, {"Citation": "Li L., Wu Y., Wang J., Yan H., Lu J., Wan Y., Zhang B., Zhang J., Yang J., Wang X., et al. Potential treatment of COVID-19 with traditional chinese medicine: What herbs can help win the battle with SARS-CoV-2? Engineering. 2021 doi: 10.1016/j.eng.2021.08.020.", "ArticleIdList": ["10.1016/j.eng.2021.08.020", "PMC8552808", "34729244"]}, {"Citation": "Chapman R.L., Andurkar S.V. A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19. Med. Chem. Res. 2022;31:40\u201351. doi: 10.1007/s00044-021-02826-2.", "ArticleIdList": ["10.1007/s00044-021-02826-2", "PMC8636070", "34873386"]}, {"Citation": "Lyu M., Fan G.W., Xiao G.X., Wang T.Y., Xu D., Gao J., Ge S.Q., Li Q.L., Ma Y.L., Zhang H., et al. Traditional Chinese medicine in COVID-19. Acta Pharm. Sin. B. 2021;11:3337\u20133363. doi: 10.1016/j.apsb.2021.09.008.", "ArticleIdList": ["10.1016/j.apsb.2021.09.008", "PMC8450055", "34567957"]}, {"Citation": "Liu H., Ye F., Sun Q., Liang H., Li C., Li S., Lu R., Huang B., Tan W., Lai L. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J. Enzym. Inhib. Med. Chem. 2021;36:497\u2013503. doi: 10.1080/14756366.2021.1873977.", "ArticleIdList": ["10.1080/14756366.2021.1873977", "PMC7850424", "33491508"]}, {"Citation": "Crampon K., Giorkallos A., Deldossi M., Baud S., Steffenel L.A. Machine-learning methods for ligand-protein molecular docking. Drug Discov. Today. 2022;27:151\u2013164. doi: 10.1016/j.drudis.2021.09.007.", "ArticleIdList": ["10.1016/j.drudis.2021.09.007", "34560276"]}, {"Citation": "Li W.X., Tong X., Yang P.P., Zheng Y., Liang J.H., Li G.H., Liu D., Guan D.G., Dai S.X. Screening of antibacterial compounds with novel structure from the FDA approved drugs using machine learning methods. Aging. 2022;14:1448\u20131472. doi: 10.18632/aging.203887.", "ArticleIdList": ["10.18632/aging.203887", "PMC8876917", "35150482"]}, {"Citation": "Batista G.E., Prati R.C., Monard M.C. A study of the behavior of several methods for balancing machine learning training data. ACM SIGKDD Explor. Newsl. 2004;6:20\u201329. doi: 10.1145/1007730.1007735.", "ArticleIdList": ["10.1145/1007730.1007735"]}, {"Citation": "Yang L., Shami A. On hyperparameter optimization of machine learning algorithms: Theory and practice. Neurocomputing. 2020;415:295\u2013316. doi: 10.1016/j.neucom.2020.07.061.", "ArticleIdList": ["10.1016/j.neucom.2020.07.061"]}, {"Citation": "Branco P., Torgo L., Ribeiro R.P. A survey of predictive modeling on imbalanced domains. ACM Comput. Surv. 2016;49:1\u201350. doi: 10.1145/2907070.", "ArticleIdList": ["10.1145/2907070"]}, {"Citation": "Sun Z.B., Song Q.B., Zhu X.Y., Sun H.L., Xu B.W., Zhou Y.M. A novel ensemble method for classifying imbalanced data. Pattern Recogn. 2015;48:1623\u20131637. doi: 10.1016/j.patcog.2014.11.014.", "ArticleIdList": ["10.1016/j.patcog.2014.11.014"]}, {"Citation": "Yen S.J., Lee Y.S. Cluster-based under-sampling approaches for imbalanced data distributions. Expert Syst. Appl. 2009;36:5718\u20135727. doi: 10.1016/j.eswa.2008.06.108.", "ArticleIdList": ["10.1016/j.eswa.2008.06.108"]}, {"Citation": "Wigh D.S., Goodman J.M., Lapkin A.A. A review of molecular representation in the age of machine learning. Wires Comput. Mol. Sci. 2022;12:e1603. doi: 10.1002/wcms.1603.", "ArticleIdList": ["10.1002/wcms.1603"]}, {"Citation": "Muegge I., Mukherjee P. An overview of molecular fingerprint similarity search in virtual screening. Expert Opin. Drug Discov. 2016;11:137\u2013148. doi: 10.1517/17460441.2016.1117070.", "ArticleIdList": ["10.1517/17460441.2016.1117070", "26558489"]}, {"Citation": "Mendez D., Gaulton A., Bento A.P., Chambers J., De Veij M., Felix E., Magarinos M.P., Mosquera J.F., Mutowo P., Nowotka M., et al. ChEMBL: Towards direct deposition of bioassay data. Nucleic Acids Res. 2019;47:D930\u2013D940. doi: 10.1093/nar/gky1075.", "ArticleIdList": ["10.1093/nar/gky1075", "PMC6323927", "30398643"]}, {"Citation": "Rajput A., Thakur A., Rastogi A., Choudhury S., Kumar M. Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis. Comput. Biol. Med. 2021;136:104677. doi: 10.1016/j.compbiomed.2021.104677.", "ArticleIdList": ["10.1016/j.compbiomed.2021.104677", "PMC8299294", "34332351"]}, {"Citation": "Deng Y.H., Wang N.N., Zou Z.X., Zhang L., Xu K.P., Chen A.F., Cao D.S., Tan G.S. Multi-Target Screening and Experimental Validation of Natural Products from Selaginella Plants against Alzheimer\u2019s Disease. Front. Pharmacol. 2017;8:539. doi: 10.3389/fphar.2017.00539.", "ArticleIdList": ["10.3389/fphar.2017.00539", "PMC5574911", "28890698"]}, {"Citation": "Qureshi A., Kaur G., Kumar M. AVCpred: An integrated web server for prediction and design of antiviral compounds. Chem. Biol. Drug Des. 2017;89:74\u201383. doi: 10.1111/cbdd.12834.", "ArticleIdList": ["10.1111/cbdd.12834", "PMC7162012", "27490990"]}, {"Citation": "Sander J.F.T., von Korff M., Rufener C. DataWarrior: An Open-Source Program for Chemistry Aware Data Visualization and Analysis. J. Chem. Inf. Model. 2015;55:460\u2013473. doi: 10.1021/ci500588j.", "ArticleIdList": ["10.1021/ci500588j", "25558886"]}, {"Citation": "O\u2019Boyle N.M., Morley C., Hutchison G.R. Pybel: A Python wrapper for the OpenBabel cheminformatics toolkit. Chem. Cent. J. 2008;2:5. doi: 10.1186/1752-153X-2-5.", "ArticleIdList": ["10.1186/1752-153X-2-5", "PMC2270842", "18328109"]}, {"Citation": "De Clercq E., Li G. Approved Antiviral Drugs over the Past 50 Years. Clin. Microbiol. Rev. 2016;29:695\u2013747. doi: 10.1128/CMR.00102-15.", "ArticleIdList": ["10.1128/CMR.00102-15", "PMC4978613", "27281742"]}, {"Citation": "Tompa D.R., Immanuel A., Srikanth S., Kadhirvel S. Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. Int. J. Biol. Macromol. 2021;172:524\u2013541. doi: 10.1016/j.ijbiomac.2021.01.076.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.01.076", "PMC8055758", "33454328"]}, {"Citation": "Willett P., Barnard J.M., Downs G.M. Chemical similarity searching. J. Chem. Inf. Comput. Sci. 1998;38:983\u2013996. doi: 10.1021/ci9800211.", "ArticleIdList": ["10.1021/ci9800211"]}, {"Citation": "Dragos H., Gilles M., Alexandre V. Predicting the predictability: A unified approach to the applicability domain problem of QSAR models. J. Chem. Inf. Model. 2009;49:1762\u20131776. doi: 10.1021/ci9000579.", "ArticleIdList": ["10.1021/ci9000579", "19530661"]}, {"Citation": "Sahigara F., Mansouri K., Ballabio D., Mauri A., Consonni V., Todeschini R. Comparison of different approaches to define the applicability domain of QSAR models. Molecules. 2012;17:4791\u20134810. doi: 10.3390/molecules17054791.", "ArticleIdList": ["10.3390/molecules17054791", "PMC6268288", "22534664"]}, {"Citation": "Sun L.X., Yang H.B., Li J., Wang T.D.Y., Li W.H., Liu G.X., Tang Y. In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models. ChemMedChem. 2018;13:572\u2013581. doi: 10.1002/cmdc.201700582.", "ArticleIdList": ["10.1002/cmdc.201700582", "29057587"]}, {"Citation": "Chen Y., Yang H.B., Wu Z.R., Liu G.X., Tang Y., Li W.H. Prediction of Farnesoid X Receptor Disruptors with Machine Learning Methods. Chem. Res. Toxicol. 2018;31:1128\u20131137. doi: 10.1021/acs.chemrestox.8b00162.", "ArticleIdList": ["10.1021/acs.chemrestox.8b00162", "30371063"]}, {"Citation": "Tian Y.J., Zhang S.D., Yin H.Y., Yan A.X. Quantitative structure-activity relationship (QSAR) models and their applicability domain analysis on HIV-1 protease inhibitors by machine learning methods. Chemometr. Intell. Lab. 2020;196:103888. doi: 10.1016/j.chemolab.2019.103888.", "ArticleIdList": ["10.1016/j.chemolab.2019.103888"]}, {"Citation": "Golbraikh A., Shen M., Xiao Z., Xiao Y.D., Lee K.H., Tropsha A. Rational selection of training and test sets for the development of validated QSAR models. J. Comput. Aided Mol. Des. 2003;17:241\u2013253. doi: 10.1023/A:1025386326946.", "ArticleIdList": ["10.1023/A:1025386326946", "13677490"]}, {"Citation": "Wu T., Hu E., Xu S., Chen M., Guo P., Dai Z., Feng T., Zhou L., Tang W., Zhan L., et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. doi: 10.1016/j.xinn.2021.100141.", "ArticleIdList": ["10.1016/j.xinn.2021.100141", "PMC8454663", "34557778"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "29"}, {"Year": "2022", "Month": "12", "Day": "17"}, {"Year": "2022", "Month": "12", "Day": "23"}, {"Year": "2023", "Month": "1", "Day": "8", "Hour": "1", "Minute": "34"}, {"Year": "2023", "Month": "1", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["36615401", "PMC9821958", "10.3390/molecules28010208", "molecules28010208"]}}], "PubmedBookArticle": []}